Episodes

  • Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Therapy

    Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Therapy
    Apr 22 2025

    Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.

    CME information and select publications here.

    Show more Show less
    40 mins
  • Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2

    Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2
    Apr 18 2025

    Nurse practitioner Ms Amy Goodrich from The Sidney Kimmel Comprehensive Care Center in Baltimore, Maryland, presents cases from her practice illustrating the efficacy and safety of bispecific antibodies for non-Hodkin lymphoma.

    NCPD information and select publications here.
    Show more Show less
    58 mins
  • Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

    Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
    Apr 15 2025

    Dr Raajit K Rampal from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and novel treatment strategies for myelofibrosis.

    CME information and select publications here.
    Show more Show less
    43 mins
  • Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit

    Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit
    Apr 12 2025

    Clinical investigators discuss available data guiding the management of chronic lymphocytic leukemia. 

    CME information and select publications here.
    Show more Show less
    50 mins
  • Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences

    Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences
    Apr 4 2025

    Dr Catherine C Coombs from UCI Health in Orange County, California, discusses patient cases from her practice and provides an overview of existing and emerging treatment approaches for chronic lymphocytic leukemia.

    CME information and select publications here.

    Show more Show less
    58 mins
  • Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses

    Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses
    Mar 24 2025

    Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.

    NCPD information and select publications here.

    Show more Show less
    1 hr and 5 mins
  • Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1

    Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1
    Mar 18 2025

    Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma.

    NCPD information and select publications here.
    Show more Show less
    1 hr and 6 mins
  • Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies

    Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies
    Feb 25 2025

    Prof Martin Hutchings from Copenhagen University Hospital in Denmark, Dr Manali Kamdar from the University of Colorado Cancer Center, Dr Matthew Lunning from the University of Nebraska Medical Center and Prof Gilles Salles from Memorial Sloan Kettering Cancer Center in New York summarize currently available data guiding treatment decision-making for patients with relapsed/refractory diffuse large B-cell lymphoma and present cases from their practices.

    CME information and select publications here.
    Show more Show less
    2 hrs and 33 mins
adbl_web_global_use_to_activate_webcro768_stickypopup